These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 14136756)

  • 1. ["2ND LINE" DRUG THERAPY IN CHRONIC TUBERCULOSIS DUE TO GERM RESISTANCE. (NEW METHODS OF DRUG ADMINISTRATION; NEW DRUGS)].
    HAMMERLI A; KRAMER EE; GALLINDO IS
    Hospital (Rio J); 1964 Feb; 65():365-88. PubMed ID: 14136756
    [No Abstract]   [Full Text] [Related]  

  • 2. [ANTIMICROBIAL TREATMENT OF TUBERCULOSIS WITH SUBSIDIARY DRUGS. 2ND LINE DRUGS].
    ACEVEDO RC; HERRERO JJ; PILHEU J; RODRIGUEZ E
    Sem Med; 1964 Mar; 124():534-43. PubMed ID: 14156391
    [No Abstract]   [Full Text] [Related]  

  • 3. CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. II. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF ETHAMBUTOL, CAPREOMYCIN AND COMPANION DRUGS, INCLUDING 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE.
    KASS I
    Tubercle; 1965 Jun; 46():166-77. PubMed ID: 14327964
    [No Abstract]   [Full Text] [Related]  

  • 4. [BACTERIAL RESISTANCE TO SUBSIDIARY ANTITUBERCULAR DRUGS].
    REY JC; CETRANGOLO A; DUBRA FA
    Medicina (B Aires); 1964; 24():273-6. PubMed ID: 14216722
    [No Abstract]   [Full Text] [Related]  

  • 5. ETHIONAMIDE-CYCLOSERINE THERAPY FOR AMBULATORY PATIENTS WITH PULMONARY TUBERCULOSIS UNRESPONSIVE TO STANDARD DRUGS.
    CHAVES AD; ABELES H; ROBINS AB
    Am Rev Respir Dis; 1963 Aug; 88():254-6. PubMed ID: 14045232
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE TREATMENT OF TUBERCULOSIS WITH 2ND LINE DRUGS].
    SCHWARTZ WS
    Sem Med; 1964 Mar; 124():523-34. PubMed ID: 14156390
    [No Abstract]   [Full Text] [Related]  

  • 7. THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS.
    SCHLESS JM; ALLISON RF; INGLIS RM; WHITE EF; TOPPERMAN S
    Am Rev Respir Dis; 1965 May; 91():728-37. PubMed ID: 14280946
    [No Abstract]   [Full Text] [Related]  

  • 8. [ANTIMICROBIAL SCREEN IN PHTHISIOLOGICAL SURGERY].
    SNAJDR V; KRAKORA P; FISER F; CHODOUNSKA V
    Rozhl Chir; 1963 Oct; 42():712-20. PubMed ID: 14119837
    [No Abstract]   [Full Text] [Related]  

  • 9. [ASSOCIATION OF ETHIONAMIDE-CYCLOSERINE IN THE TREATMENT OF PULMONARY TUBERCULOSIS WITH GERMS RESISTANT TO THE 1ST LINE DRUGS].
    PEREZ JA; FARIAS CE
    Rev Esp Tuberc; 1964 May; 33():197-208. PubMed ID: 14169311
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
    Fegiz G
    Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
    [No Abstract]   [Full Text] [Related]  

  • 11. [ETHIONAMIDE IN ASSOCIATION WITH PYRAZINAMIDE OR CYCLOSERINE IN THE TREATMENT OF CHRONIC PULMONARY TUBERCULOSIS].
    WAGNER J
    Gruzlica (1926); 1963 Dec; 31():1217-22. PubMed ID: 14107826
    [No Abstract]   [Full Text] [Related]  

  • 12. Bacteriological aspects of the use of ethionamide, pyrazinamide and cycloserine in the treatment of chronic pulmonary tuberculosis.
    STEWART SM; HALL E; RIDDELL RW; SOMNER AR
    Tubercle; 1962 Dec; 43():417-31. PubMed ID: 13993194
    [No Abstract]   [Full Text] [Related]  

  • 13. [ETHIONAMIDE-CYCLOSERINE COMBINATION IN THE TREATMENT OF PULMONARY TUBERCULOSIS CAUSED BY BACTERIA RESISTANT TO THE USUAL DRUGS].
    PEREZ JA; FARIAS CE
    Torax; 1963; 12():126-32. PubMed ID: 14158168
    [No Abstract]   [Full Text] [Related]  

  • 14. A controlled comparison of cycloserine plus ethionamide with cycloserine plus thiacetazone in patients with active pulmonary tuberculosis despite prolonged previous chemotherapy.
    ANGEL JH; BHATIA AL; DEVADATTA S; FOX W; JANARDHANAM B; RADHAKRISHNA S; RAMAKRISHNAN CV; SELKON JB; STOTT H; VELU S
    Tubercle; 1963 Jun; 44():215-24. PubMed ID: 14013125
    [No Abstract]   [Full Text] [Related]  

  • 15. [DRUG TREATMENT OF RENAL TUBERCULOSIS].
    TUOVINEN PI; SUTINEN S
    Suom Laakaril; 1964 Aug; 19():1629-38. PubMed ID: 14179990
    [No Abstract]   [Full Text] [Related]  

  • 16. CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. I. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF KANAMYCIN, ETHIONAMIDE AND EITHER CYCLOSERINE OR PYRAZINAMIDE.
    KASS I
    Tubercle; 1965 Jun; 46():151-65. PubMed ID: 14327963
    [No Abstract]   [Full Text] [Related]  

  • 17. [UROGENITAL TUBERCULOSIS: PATHOGENESIS, DIAGNOSIS AND THERAPY. SURVEY OF THE MOST IMPORTANT PUBLICATIONS OF THE LAST YEARS].
    ALBRECHT KF
    Urologe; 1964 Jan; 3():33-7. PubMed ID: 14160920
    [No Abstract]   [Full Text] [Related]  

  • 18. [EFFECTS OF ETHIONAMIDE ON TUBERCLE BACILLI RESISTANT TO VARIOUS ANTITUBERCULAR AGENTS AND THE EFFECTS OF THESE AGENTS ON ETHIONAMIDE-RESISTANT TUBERCLE BACILLI].
    TSUCHIMOCHI T
    Kekkaku; 1963 Jun; 38():264-9. PubMed ID: 14046673
    [No Abstract]   [Full Text] [Related]  

  • 19. [ETHIONAMIDE IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
    ZIERSKI M
    G Ital Chemioter; 1963; 10():110-7. PubMed ID: 14074246
    [No Abstract]   [Full Text] [Related]  

  • 20. A PRELIMINARY REPORT ON A NEW ANTITUBERCULOUS DRUG 4-AMINO-2-HYDROXY-PHENYL-1, 3, 4,-OXADIAZOL-2-OL WS 127.
    SMITH AE; ASPEVIK E; EVENSTAD E; HAUKENES G
    Acta Tuberc Pneumol Scand; 1964; 45():231-55. PubMed ID: 14234467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.